Literature DB >> 32256862

Successful transcatheter closure of coronary artery fistula in a patient with anomalous aortic origin of the left main coronary artery from the right aortic sinus.

Mizuhiko Ishigaki1, Sung-Hae Kim1, Masaki Nii1, Keisuke Sato1, Jun Yoshimoto1, Norie Mitsushita1, Yasuhiko Tanaka1.   

Abstract

Transcatheter closure is an established method to treat coronary artery fistula (CAF). We present transcatheter closure in a 6-year-old girl with CAF and anomalous aortic origin of the left main coronary artery from the right aortic sinus. The CAF originated from the left coronary artery (LCA), coursed through the interventricular septum (intraseptal course) with prominent dilation, and drained into the right ventricular outflow tract. She underwent transcatheter closure and was in a stable condition at the 3-year follow-up with regression of the dilated portion of the intraseptal-type LCA. Hence, transcatheter closure of CAF is feasible in patients with anomalous origins of coronary arteries. <Learning objective: This report describes the feasibility and safeness of transcatheter closure of a coronary artery fistula in a patient with an anomalous origin of a coronary artery. This is the first report to visualize the regression of the markedly dilated left coronary artery with an intraseptal course.>.
© 2019 Japanese College of Cardiology. Published by Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Amplatzer vascular plug; Anomalous aortic origin of the coronary artery; Coronary artery fistula; Intraseptal course; Sudden cardiac death

Year:  2019        PMID: 32256862      PMCID: PMC7125372          DOI: 10.1016/j.jccase.2019.11.011

Source DB:  PubMed          Journal:  J Cardiol Cases        ISSN: 1878-5409


  1 in total

1.  Atypical chest pain due to multiple coronary arteries fistulas occluded with percutaneous interlock coils: A case report.

Authors:  Gustavo Iacomini Ida; Michel A Kalansky; Luciana de Pádua S Baptista; Pedro Gabriel Melo de Barros E Silva; Marcelo Jamus; José Carlos Teixeira Garcia; Valter Furlan; Expedito E Ribeiro; Henrique B Ribeiro
Journal:  J Cardiol Cases       Date:  2020-09-11
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.